Edge Pharma, LLC recalls Neostigmine methylsulfate, 5 mg/5mL (1 mg/mL), 5 mL per syringe, Single Use Syringe for IV or IM Injection, Edge Pharma,
Recalled February 2, 2022 · FDA recall D-0411-2022 · Edge Pharma
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
160 syringes
Sold at
nationwide
Description
Lack of Assurance of Sterility
Product
Neostigmine methylsulfate, 5 mg/5mL (1 mg/mL), 5 mL per syringe, Single Use Syringe for IV or IM Injection, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-1549-05
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →